Quality of laxative life
August 3, 2010
A RECENT randomised, double blind
placebo-controlled study of
the laxative agent bisacodyl, has
found that its use can increase the
quality of life, as well as everyday
functioning and well being, in
constipation sufferers.
Aimed at determining the efficacy
of 10mg oral bisacodyl tablets in
chronic constipation sufferers, the
study gathered information from
368 patients, and showed that
“treatment improved all measured
symptoms of constipation at nearly
every point assessed”.
“Oral bisacodyl proved to be an
effective, well-tolerated treatment
for patients with constipation,” said
President of the Gut Foundation
Professor Terry Bolin.
“It increased bowel frequency
and improved the associated
symptoms of constipation such as
bloating and abdominal discomfort.
“Moreover, treatment with
bisacodyl had a sustained impact:
The benefit was maintained over
the four week study period, with no
signs of habituation,” he added.
The above article was sent to subscribers in Pharmacy Daily's issue from 03 Aug 10To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 03 Aug 10
